UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Analysis of the Thymidylate Synthase Gene Structure in Colorectal Cancer Patients and Its Possible Relation with the 5-Fluorouracil Drug Response

Journal of Nucleic Acids, 2010-01, Vol.2010 (2010), p.252-255

2010

Volltextzugriff (PDF)

399 POSTER Analysis of coding and non-coding regions of thymidylate synthase gene in colorectal cancer patients and its possible relationship with 5-fluorouracil drug response

European journal of cancer supplements, 2007, Vol.5 (4), p.83-84

2007

Volltextzugriff (PDF)

CDK12 promotes tumorigenesis but induces vulnerability to therapies inhibiting folate one-carbon metabolism in breast cancer

Nature communications, 2022-05, Vol.13 (1), p.2642-2642, Article 2642

2022

Volltextzugriff (PDF)

Are We Ready to Implement Molecular Subtyping of Bladder Cancer in Clinical Practice? Part 1: General Issues and Marker Expression

International journal of molecular sciences, 2022-07, Vol.23 (14), p.7819

2022

Volltextzugriff (PDF)

Are We Ready to Implement Molecular Subtyping of Bladder Cancer in Clinical Practice? Part 2: Subtypes and Divergent Differentiation

International journal of molecular sciences, 2022-07, Vol.23 (14), p.7844

2022

Volltextzugriff (PDF)

SURFACE MODIFICATION OF A TITANIUM ALLOY: EFFECTS ON THE ADHESION OF A POLYMER-BASED COATING

International journal of artificial organs, 2023-07, Vol.46 (7), p.462

2023

Volltextzugriff (PDF)

PSA Density Help to Identify Patients With Elevated PSA Due to Prostate Cancer Rather Than Intraprostatic Inflammation: A Prospective Single Center Study

Frontiers in oncology, 2021-05, Vol.11, p.693684-693684

2021

Volltextzugriff (PDF)

Bladder biopsies to assess treatment response after intravesical Bacillus Calmette-Guerin induction cycle: Are they necessary?

European urology, 2022-02, Vol.81, p.S368

2022

Volltextzugriff (PDF)

Neoadjuvant Chemotherapy Before Radical Cystectomy: Why We Must Adhere?

Current drug targets, 2021-01, Vol.22 (1), p.14-21

2021

Volltextzugriff (PDF)

A0914 - Assessing post-operative morbidity after retrograde/anterograde ureteroscopy for upper tract urinary cancer management using the EAU quality criteria for standardized reporting

European urology, 2023-02, Vol.83, p.S1304-S1304

2023

Volltextzugriff (PDF)

Assessing post-operative morbidity after retrograde/anterograde ureteroscopy for upper tract urinary cancer management using the EAU quality criteria for standardized reporting

European urology, 2023-02, Vol.83, p.S1304

2023

Volltextzugriff (PDF)

Diagnostic Biomarkers in Renal Cell Tumors According to the Latest WHO Classification: A Focus on Selected New Entities

Cancers, 2024-05, Vol.16 (10), p.1856

2024

Volltextzugriff (PDF)

Peritumoral inflammation in prostate biopsy core predict Biochemical recurrence after active treatment for prostate cancer

European urology, 2024-03, Vol.85, p.S1093

2024

Volltextzugriff (PDF)

P044 - The rebound effect of diagnosis of csPCa, after Covid-19 pandemic

European urology, 2024-03, Vol.85, p.S58-S59

2024

Volltextzugriff (PDF)

A0298 - Peritumoral inflammation in prostate biopsy core predict Biochemical recurrence after active treatment for prostate cancer

European urology, 2024-03, Vol.85, p.S1093-S1093

2024

Volltextzugriff (PDF)

The rebound effect of diagnosis of csPCa, after Covid-19 pandemic

European urology, 2024-03, Vol.85, p.S58-S59

2024

Volltextzugriff (PDF)

24HABPM IN THE LONG TERM FOLLOW UP OF RENAL TRANSPLANT PATIENTS: FOCUS ON AN UNMET CLINICAL NEED

Journal of hypertension, 2018-06, Vol.36 Suppl 1 - ESH 2018 Abstract Book (Supplement 1), p.e120-e121

2018

Volltextzugriff (PDF)

SLEEP DISORDERED BREATHING IN RENAL TRANSPLANT PATIENTS: A LONGITUDINAL STUDY

Journal of hypertension, 2018-06, Vol.36 Suppl 1 - ESH 2018 Abstract Book (Supplement 1), p.e302-e302

2018

Volltextzugriff (PDF)

Pentraxin-3: A novel serum biomarker to predict the risk of prostate cancer in patients submitted to prostate biopsy

European urology, 2022-02, Vol.81, p.S737

2022

Volltextzugriff (PDF)

A0504 - Second-look ureteroscopy scheduling for upper tract urothelial carcinoma: Do we need to rush?

European urology, 2023-02, Vol.83, p.S718-S718

2023

Volltextzugriff (PDF)

Follow-up intensity scheme for upper tract urothelial carcinoma after nephron-sparing surgery

European urology, 2023-02, Vol.83, p.S1321-S1322

2023

Volltextzugriff (PDF)

A0926 - Follow-up intensity scheme for upper tract urothelial carcinoma after nephron-sparing surgery

European urology, 2023-02, Vol.83, p.S1321-S1322

2023

Volltextzugriff (PDF)

Second-look ureteroscopy scheduling for upper tract urothelial carcinoma: Do we need to rush?

European urology, 2023-02, Vol.83, p.S718

2023

Volltextzugriff (PDF)

A0103 - Head-to-head comparison of the American Urological Association and European Association of Urology risk stratification models of upper tract urothelial carcinoma

European urology, 2024-03, Vol.85, p.S816-S816

2024

Volltextzugriff (PDF)

1 – 25 von 142

Suche als RSS-Feed

Aktive Filter

KollektionMEDLINE

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(95)
Mit Volltextzugriff
(135)

Publikationsform

Sprache

Englisch
(141)
Portugiesisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Analysis of the Thymidylate Synthase Gene Structure in Colorectal Cancer Patients and Its Possible Relation with the 5-Fluorouracil Drug Response

399 POSTER Analysis of coding and non-coding regions of thymidylate synthase gene in colorectal cancer patients and its possible relationship with 5-fluorouracil drug response

CDK12 promotes tumorigenesis but induces vulnerability to therapies inhibiting folate one-carbon metabolism in breast cancer

Are We Ready to Implement Molecular Subtyping of Bladder Cancer in Clinical Practice? Part 1: General Issues and Marker Expression

Are We Ready to Implement Molecular Subtyping of Bladder Cancer in Clinical Practice? Part 2: Subtypes and Divergent Differentiation

SURFACE MODIFICATION OF A TITANIUM ALLOY: EFFECTS ON THE ADHESION OF A POLYMER-BASED COATING

PSA Density Help to Identify Patients With Elevated PSA Due to Prostate Cancer Rather Than Intraprostatic Inflammation: A Prospective Single Center Study

Bladder biopsies to assess treatment response after intravesical Bacillus Calmette-Guerin induction cycle: Are they necessary?

Neoadjuvant Chemotherapy Before Radical Cystectomy: Why We Must Adhere?

Initial management approach for localized/locally advanced disease is critical to guide metastatic castration-resistant prostate cancer care

A0914 - Assessing post-operative morbidity after retrograde/anterograde ureteroscopy for upper tract urinary cancer management using the EAU quality criteria for standardized reporting

Assessing post-operative morbidity after retrograde/anterograde ureteroscopy for upper tract urinary cancer management using the EAU quality criteria for standardized reporting

Diagnostic Biomarkers in Renal Cell Tumors According to the Latest WHO Classification: A Focus on Selected New Entities

Peritumoral inflammation in prostate biopsy core predict Biochemical recurrence after active treatment for prostate cancer

P044 - The rebound effect of diagnosis of csPCa, after Covid-19 pandemic

A0298 - Peritumoral inflammation in prostate biopsy core predict Biochemical recurrence after active treatment for prostate cancer

The rebound effect of diagnosis of csPCa, after Covid-19 pandemic

24HABPM IN THE LONG TERM FOLLOW UP OF RENAL TRANSPLANT PATIENTS: FOCUS ON AN UNMET CLINICAL NEED

SLEEP DISORDERED BREATHING IN RENAL TRANSPLANT PATIENTS: A LONGITUDINAL STUDY

Pentraxin-3: A novel serum biomarker to predict the risk of prostate cancer in patients submitted to prostate biopsy

A0504 - Second-look ureteroscopy scheduling for upper tract urothelial carcinoma: Do we need to rush?

Follow-up intensity scheme for upper tract urothelial carcinoma after nephron-sparing surgery

A0926 - Follow-up intensity scheme for upper tract urothelial carcinoma after nephron-sparing surgery

Second-look ureteroscopy scheduling for upper tract urothelial carcinoma: Do we need to rush?

A0103 - Head-to-head comparison of the American Urological Association and European Association of Urology risk stratification models of upper tract urothelial carcinoma

Aktive Filter

Suchergebnisse filtern